XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Unaudited Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net income $ 104,262 $ 130,371
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 9,882 8,183
Share-based compensation 8,127 6,701
Non-cash contribution to 401(k) plan 8,735 8,862
Provision for doubtful accounts 862 1,043
Other income from investment in unconsolidated entity (5,460) (3,640)
Other, net 1,245 1,160
Changes in operating assets and liabilities, net of effects of acquisitions:    
Accounts receivable, net (33,502) (64,691)
Inventories, net (307,219) (240,758)
Accounts payable and other liabilities 315,087 101,813
Other, net 1,687 3,535
Net cash provided by (used in) operating activities 103,706 (47,421)
Cash flows from investing activities:    
Purchases of short-term cash investments (200,000) 0
Capital expenditures (5,845) (7,505)
Business acquisitions, net of cash acquired (5,178) (2,989)
Proceeds from sale of property and equipment 58 56
Net cash used in investing activities (210,965) (10,438)
Cash flows from financing activities:    
Net proceeds from the sale of Common stock 281,784 0
Net proceeds from issuances of Common stock under employee related plans 10,623 8,747
Net repayments under prior revolving credit agreement 0 (56,400)
Payment of fees related to revolving credit agreement 0 (580)
Repurchases of common stock to satisfy employee withholding tax obligations (442) (2,216)
Net repayments of finance lease liabilities (1,399) (880)
Net (repayments) proceeds under current revolving credit agreement (15,400) 197,600
Dividends on Common and Class B common stock (96,765) (94,970)
Net cash provided by financing activities 178,401 51,301
Effect of foreign exchange rate changes on cash and cash equivalents (2,390) 8
Net increase (decrease) in cash and cash equivalents 68,752 (6,550)
Cash and cash equivalents at beginning of period 210,112 147,505
Cash and cash equivalents at end of period 278,864 140,955
Supplemental cash flow information:    
Common stock issued for Commercial Specialists, Inc. $ 752 $ 0